{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:25:36Z","timestamp":1792578336724,"version":"4.5.0"},"reference-count":95,"publisher":"Oncology Nursing Society (ONS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncology Nursing Forum"],"published-print":{"date-parts":[[2007,9,1]]},"DOI":"10.1188\/07.onf.981-994","type":"journal-article","created":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T10:47:11Z","timestamp":1190285231000},"page":"981-994","source":"Crossref","is-referenced-by-count":102,"title":["Chemotherapy-Related Change in Cognitive Function: A Conceptual Model"],"prefix":"10.1188","volume":"34","author":[{"given":"Lisa M.","family":"Hess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen C.","family":"Insel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1302","published-online":{"date-parts":[[2007,9,18]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Abayomi, O.K. (2002). Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. <i>Acta Oncologica, 41<\/i>, 346-351.","DOI":"10.1080\/028418602760169389"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Ahles, T.A., & Saykin, A. (2001). Cognitive effects of standard-dose chemotherapy in patients with cancer. <i>Cancer Investigation, 19<\/i>, 812-820.","DOI":"10.1081\/CNV-100107743"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Ahles, T.A., & Saykin, A.J. (2002). Breast cancer chemotherapy-related cognitive dysfunction. <i>Clinical Breast Cancer, 3<\/i>(Suppl. 3), S84-S90.","DOI":"10.3816\/CBC.2002.s.018"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Ahles, T.A., Saykin, A.J., Furstenberg, C.T., Cole, B., Mott, L. A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. <i>Journal of Clinical Oncology, 20<\/i>, 485-493.","DOI":"10.1200\/JCO.2002.20.2.485"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Ahles, T.A., Saykin, A.J., Noll, W.W., Furstenberg, C.T., Guerin, S., Cole, B., et al. (2003). The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. <i>Psycho-Oncology, 12<\/i>, 612-619.","DOI":"10.1002\/pon.742"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Ahles, T.A., Silberfarb, P.M., Herndon, J., II, Maurer, L.H., Kornblith, A.B., Aisner, J., et al. (1998). Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: A study by the Cancer and Leukemia Group B. <i>Journal of Clinical Oncology, 16<\/i>, 1954-1960.","DOI":"10.1200\/JCO.1998.16.5.1954"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Andersen, B.L. (2002). Biobehavioral outcomes following psychological interventions for cancer patients. <i>Journal of Consulting and Clinical Psychology, 70<\/i>, 590-610.","DOI":"10.1037\/0022-006X.70.3.590"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Anderson-Hanley, C., Sherman, M.L., Riggs, R., Agocha, V.B., & Compas, B.E. (2003). Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature. <i>Journal of the International Neuropsychological Society, 9<\/i>, 967-982.","DOI":"10.1017\/S1355617703970019"},{"key":"E00009","unstructured":"Aziz, N., & Krouse, R. (2005). Cancer survivorship. In D.S. Alberts & L.M. Hess (Eds.), Fundamentals of cancer prevention (pp. 363-391). Heidelberg: Springer Verlag."},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Baron, R.M. & Kenny, D.A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. <i>Journal of Personality and Social Psychology, 51<\/i>, 1173-1182.","DOI":"10.1037\/0022-3514.51.6.1173"},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Barton, D., & Loprinzi, C. (2002). Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: The art of the possible. <i>Clinical Breast Cancer, 3<\/i>(Suppl. 3), S121-S127.","DOI":"10.3816\/CBC.2002.s.023"},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Bender, C.M., Paraska, K.K., Sereika, S.M., Ryan, C.M., & Berga, S.L. (2001). Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: A critical review. <i>Journal of Pain and Symptom Management, 21<\/i>, 407-424.","DOI":"10.1016\/S0885-3924(01)00268-8"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Bennett, D.A., Wilson, R.S., Schneider, J.A., Evans, D.A., Mendes de Leon, C.F., Arnold, S.E., et al. (2003). Education modifies the relation of AD pathology to level of cognitive function in older persons. <i>Neurology, 60<\/i>, 1909-1915.","DOI":"10.1212\/01.WNL.0000069923.64550.9F"},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Brezden, C.B., Phillips, K.A., Abdolell, M., Bunston, T. & Tannock, I.F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. <i>Journal of Clinical Oncology, 18<\/i>, 2695-2701.","DOI":"10.1200\/JCO.2000.18.14.2695"},{"key":"E00015","unstructured":"Centre for Evidence-Based Medicine. (2001). Levels of evidence and grades of recommendation. Retrieved January 31, 2007, from <a target=\"_blank\" href='http:\/\/www.cebm.net\/levels_of_evidence.asp#top'>http:\/\/www.cebm.net\/levels_of_evidence.asp#top<\/a>"},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Chaiken, S.R., Kyllonen, P.C., & Tirre, W.C. (2000). Organization and components of psychomotor ability. <i>Cognitive Psychology, 40<\/i>, 198-226.","DOI":"10.1006\/cogp.1999.0729"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Chang, E.L., & Lo, S. (2003). Diagnosis and management of central nervous system metastases from breast cancer. <i>Oncologist, 8<\/i>, 398-410.","DOI":"10.1634\/theoncologist.8-5-398"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Cimprich, B., & Ronis, D.L. (2001). Attention and symptom distress in women with and without breast cancer. <i>Nursing Research, 50<\/i>, 86-94.","DOI":"10.1097\/00006199-200103000-00004"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Cimprich, B., So, H., Ronis, D.L., & Trask, C. (2005). Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. <i>Psycho-Oncology, 14<\/i>, 70-78.","DOI":"10.1002\/pon.821"},{"key":"E00020","unstructured":"Coons, S.J., & Craig, B.M. (2005). Assessing human and economic benefits of cancer prevention. In D. S. Alberts & L.M. Hess (Eds.), <i>Fundamentals of cancer prevention<\/i> (pp. 11-24). Heidelberg: Springer-Verlag."},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Cull, A., Hay, C., Love, S.B., Mackie, M., Smets, E., & Stewart, M. (1996). What do cancer patients mean when they complain of concentration and memory problems? <i>British Journal of Cancer, 74<\/i>, 1674-1679.","DOI":"10.1038\/bjc.1996.608"},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Cunningham, R.S. (2003). Anemia in the oncology patient: Cognitive function and cancer. <i>Cancer Nursing, 26<\/i>(Suppl. 6), 38S-42S.","DOI":"10.1097\/00002820-200312001-00009"},{"key":"E00023","unstructured":"Davidson, J.E., & Downing, C.L. (2000). Contemporary models of intelligence. In R.J. Sternberg (Ed.), <i>Handbook of intelligence<\/i>. New York: Cambridge University Press."},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Degl'Innocenti, A., Elmfeldt, D., Hansson, L., Breteler, M., James, O., Lithell, H., et al. (2002). Cognitive function and health-related quality of life in elderly patients with hypertension\u2014Baseline data from the Study on Cognition and Prognosis in the Elderly (SCOPE). <i>Blood Pressure, 11<\/i>, 157-165.","DOI":"10.1080\/080370502760050395"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Degner, L.F., Hack, T., O'Neil, J., & Kristjanson, L.J. (2003). A new approach to eliciting meaning in the context of breast cancer. <i>Cancer Nursing, 26<\/i>, 169-178.","DOI":"10.1097\/00002820-200306000-00001"},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Erlanger, D.M., Feldman, D.J., Kaplan, D., and Theodoracopulos, A. (2000). Development and validation of the cognitive stability index, a web-based protocol for monitoring change in cognitive function. <i>Archives of Clinical Neuropsychology, 15<\/i>, 693-694.","DOI":"10.1093\/arclin\/15.8.693a"},{"key":"E00027","doi-asserted-by":"crossref","unstructured":"Fliessbach, K., Urbach, H., Helmstaedter, C., Pels, H., Glasmacher, A., Kraus, J.A., et al. (2003). Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma. <i>Archives of Neurology, 60<\/i>, 563-568.","DOI":"10.1001\/archneur.60.4.563"},{"key":"E00028","doi-asserted-by":"crossref","unstructured":"Foster, L.W., & McLellan, L. (2000). Cognition and the cancer experience: Clinical implications. <i>Cancer Practice, 8<\/i>, 25-31.","DOI":"10.1046\/j.1523-5394.2000.81004.x"},{"key":"E00029","doi-asserted-by":"crossref","unstructured":"Frytak, S., Shaw, J.N., Lee, R.E., Eagan, R.T., Shaw, E.G., Richardson, R.L., et al. (1988). Treatment toxicities in long-term survivors of limited small cell lung cancer. <i>Cancer Investigation, 6<\/i>, 669-676.","DOI":"10.3109\/07357908809078033"},{"key":"E00030","doi-asserted-by":"crossref","unstructured":"Gottschalk, L.A., Holcombe, R.F., Jackson, D., & Bechtel, R.J. (2003). The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients. <i>Methods and Findings in Experimental and Clinical Pharmacology, 25<\/i>, 117-122.","DOI":"10.1358\/mf.2003.25.2.723685"},{"key":"E00031","doi-asserted-by":"crossref","unstructured":"Graves, K.D. (2003). Social cognitive theory and cancer patients' quality of life: A meta-analysis of psychosocial intervention components. <i>Health Psychology, 22<\/i>, 210-219.","DOI":"10.1037\/0278-6133.22.2.210"},{"key":"E00032","doi-asserted-by":"crossref","unstructured":"Groopman, J.E., & Itri, L.M. (1999). Chemotherapy-induced anemia in adults: Incidence and treatment. <i>Journal of the National Cancer Institute, 91<\/i>, 1616-1634.","DOI":"10.1093\/jnci\/91.19.1616"},{"key":"E00033","doi-asserted-by":"crossref","unstructured":"Hensley, M.L., Correa, D.D., Thaler, H., Wilton, A., Venkatraman, E., Sabbatini, P., et al. (2006). Phase I\/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning. <i>Gynecologic Oncology, 102<\/i>, 270-277.","DOI":"10.1016\/j.ygyno.2005.12.042"},{"key":"E00034","doi-asserted-by":"crossref","unstructured":"Hurria, A., Goldfarb, S., Rosen, C., Holland, J., Zuckerman, E., Lachs, M.S., et al. (2006). Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. <i>Breast Cancer Research and Treatment, 98<\/i>, 343-348.","DOI":"10.1007\/s10549-006-9171-6"},{"key":"E00035","doi-asserted-by":"crossref","unstructured":"Jacobsen, P.B., Garland, L.L., Booth-Jones, M., Donovan, K.A., Thors, C.L., Winters, E., et al. (2004). Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. <i>Journal of Pain and Symptom Management, 28<\/i>, 7-18.","DOI":"10.1016\/j.jpainsymman.2003.11.002"},{"key":"E00036","doi-asserted-by":"crossref","unstructured":"Jansen, C., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005a). A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. <i>Cancer, 104<\/i>, 2222-2233.","DOI":"10.1002\/cncr.21469"},{"key":"E00037","doi-asserted-by":"crossref","unstructured":"Jansen, C., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005b). Potential mechanisms for chemotherapy-induced impairments in cognitive function. <i>Oncology Nursing Forum, 32<\/i>, 1151-1163.","DOI":"10.1188\/05.ONF.1151-1163"},{"key":"E00038","doi-asserted-by":"crossref","unstructured":"Joly, F., Alibhai, S.M., Galica, J., Park, A., Yi, Q.L., Wagner, L., et al. (2006). Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. <i>Journal of Urology, 176<\/i>, 2443-2447.","DOI":"10.1016\/j.juro.2006.07.151"},{"key":"E00039","doi-asserted-by":"crossref","unstructured":"Kaplan, C.P., & Miner, M.E. (1998). Does the SCL 90-R obsessive-compulsive dimension identify cognitive impairments? <i>Journal of Head Trauma Rehabilitation, 13<\/i>(3), 94-101.","DOI":"10.1097\/00001199-199806000-00009"},{"key":"E00040","doi-asserted-by":"crossref","unstructured":"Keime-Guibert, F., Napolitano, M., & Delattre, J.Y. (1998). Neurological complications of radiotherapy and chemotherapy. <i>Journal of Neurology, 245<\/i>, 695-708.","DOI":"10.1007\/s004150050271"},{"key":"E00041","doi-asserted-by":"crossref","unstructured":"Kiessling, A., & Henriksson, P. (2004). Perceived cognitive function is a major determinant of health related quality of life in a non-selected population of patients with coronary artery disease\u2014A principal components analysis. <i>Quality of Life Research, 13<\/i>, 1621-1631.","DOI":"10.1007\/s11136-004-7863-0"},{"key":"E00042","doi-asserted-by":"crossref","unstructured":"Klepstad, P., Hilton, P., Moen, J., Fougner, B., Borchgrevink, P.C., & Kaasa, S. (2002). Self-reports are not related to objective assessments of cognitive function and sedation in patients with cancer pain admitted to a palliative care unit. <i>Palliative Medicine, 16<\/i>, 513-519.","DOI":"10.1191\/0269216302pm587oa"},{"key":"E00043","doi-asserted-by":"crossref","unstructured":"Komaki, R., Meyers, C.A., Shin, D.M., Garden, A.S., Byrne, K., Nickens, J.A., et al. (1995). Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. <i>International Journal of Radiation Oncology Biology and Physics, 33<\/i>, 179-182.","DOI":"10.1016\/0360-3016(95)00026-U"},{"key":"E00044","unstructured":"Licinio, J., Kling, M.A., & Hauser, P. (1998). Cytokines and brain function: Relevance to interferon-alpha-induced mood and cognitive changes. <i>Seminars in Oncology, 25<\/i>(Suppl. 1), 30-38."},{"key":"E00045","doi-asserted-by":"crossref","unstructured":"Lilja, A.M., Portin, R.I., Hamalainen, P.I., & Salminen, E.K. (2001). Short-term effects of radiotherapy on attention and memory performances in patients with brain tumors. <i>Cancer, 91<\/i>, 2361-2368.","DOI":"10.1002\/1097-0142(20010615)91:12<2361::AID-CNCR1269>3.0.CO;2-1"},{"key":"E00046","unstructured":"MacKinnon, D.P. (2002). Statistical mediation. Retrieved January 29, 2007, from <a target=\"_blank\" href='http:\/\/www.public.asu.edu\/~davidpm\/ripl\/mediate.htm'>http:\/\/www.public.asu.edu\/~davidpm\/ripl\/mediate.htm<\/a>"},{"key":"E00047","doi-asserted-by":"crossref","unstructured":"Massa, E., Madeddu, C., Lusso, M.R., Gramignano, G., & Mantovani, G. (2006). Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. <i>Critical Reviews in Oncology\/Hematology, 57<\/i>, 175-182.","DOI":"10.1016\/j.critrevonc.2005.06.001"},{"key":"E00048","unstructured":"Matlin, M.W. (2003). <i>Cognition<\/i>. Geneseo, NY: John Wiley and Sons."},{"key":"E00049","unstructured":"Mayerhofer, K., Bodner-Adler, B., Bodner, K., Saletu, B., Schindl, M., Kaider, A., et al. (2000). A paclitaxel-containing chemotherapy does not cause central nervous adverse effects: A prospective study in patients with ovarian cancer. <i>Anticancer Research, 20<\/i>(5C), 4051-4055."},{"key":"E00050","doi-asserted-by":"crossref","unstructured":"McCracken, L.M., & Iverson, G.L. (2001). Predicting complaints of impaired cognitive functioning in patients with chronic pain. <i>Journal of Pain and Symptom Management, 21<\/i>, 392-396.","DOI":"10.1016\/S0885-3924(01)00267-6"},{"key":"E00051","unstructured":"Meyers, C.A. (2000). Neurocognitive dysfunction in cancer patients. <i>Oncology, 14<\/i>, 75-79."},{"key":"E00052","doi-asserted-by":"crossref","unstructured":"Meyers, C.A., & Wefel, J.S. (2003). The use of the mini-mental state examination to assess cognitive functioning in cancer trials: No ifs, ands, buts, or sensitivity. <i>Journal of Clinical Oncology, 21<\/i>, 3557-3558.","DOI":"10.1200\/JCO.2003.07.080"},{"key":"E00053","unstructured":"Miller, I.E. (1909). <i>The psychology of thinking<\/i>. New York: MacMillan Company."},{"key":"E00054","unstructured":"Miller, K.D. (2001). Chemotherapy and cognitive function: Maybe its all in their heads? <i>37th Annual Meeting of the American Society of Clinical Oncology Breast Cancer CME<\/i>. Retrieved January 31, 2007 <a target=\"_blank\" href='http:\/\/www.medscape.com\/viewarticle\/418462'>http:\/\/www.medscape.com\/viewarticle\/418462<\/a>"},{"key":"E00055","doi-asserted-by":"crossref","unstructured":"Mitchell, R.L., & Phillips, L.H. (2007). The psychological, neurochemical and functional neuroanatomical mediators of the effects of positive and negative mood on executive functions. <i>Neuropsychologia, 45<\/i>, 617-629.","DOI":"10.1016\/j.neuropsychologia.2006.06.030"},{"key":"E00056","doi-asserted-by":"crossref","unstructured":"Miyake, A., Friedman, N.P., Rettinger, D.A., Shah, P., & Hegarty, M. (2001). How are visuospatial working memory, executive functioning, and spatial abilities related? A latent-variable analysis. <i>Journal of Experimental Psychology: General, 130<\/i>, 621-640.","DOI":"10.1037\/0096-3445.130.4.621"},{"key":"E00057","doi-asserted-by":"crossref","unstructured":"Moher, D., Cook, D.J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D.F. (2000). Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. <i>British Journal of Surgery, 87<\/i>, 1448-1454.","DOI":"10.1046\/j.1365-2168.2000.01610.x"},{"key":"E00058","doi-asserted-by":"crossref","unstructured":"Moher, D., Schulz, K.F., & Altman, D. (2005). The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. <i>Explore (NY), 1<\/i>, 40-45.","DOI":"10.1016\/j.explore.2004.11.001"},{"key":"E00059","unstructured":"Olin, J.J. (2001). Cognitive function after systemic therapy for breast cancer. <i>Oncology (Williston Park), 15<\/i>, 613-618."},{"key":"E00060","doi-asserted-by":"crossref","unstructured":"O'Shaughnessy, J.A. (2002). Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy. <i>Clinical Breast Cancer, 3<\/i>(Suppl. 3), S116-S120.","DOI":"10.3816\/CBC.2002.s.022"},{"key":"E00061","doi-asserted-by":"crossref","unstructured":"Paganini-Hill, A., & Clark, L.J. (2000). Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. <i>Breast Cancer Research and Treatment, 64<\/i>, 165-176.","DOI":"10.1023\/A:1006426132338"},{"key":"E00062","doi-asserted-by":"crossref","unstructured":"Paraska, K., & Bender, C.M. (2003). Cognitive dysfunction following adjuvant chemotherapy for breast cancer: Two case studies. <i>Oncology Nursing Forum, 30<\/i>, 473-478.","DOI":"10.1188\/03.ONF.473-478"},{"key":"E00063","doi-asserted-by":"crossref","unstructured":"Phillips, K.A., & Bernhard, J. (2003). Adjuvant breast cancer treatment and cognitive function: Current knowledge and research directions. <i>Journal of the National Cancer Institute, 95<\/i>, 190-197.","DOI":"10.1093\/jnci\/95.3.190"},{"key":"E00064","doi-asserted-by":"crossref","unstructured":"Salminen, E., Portin, R., Korpela, J., Backman, H., Parvinen, L.M., Helenius, H., et al. (2003). Androgen deprivation and cognition in prostate cancer. <i>British Journal of Cancer, 89<\/i>, 971-976.","DOI":"10.1038\/sj.bjc.6601235"},{"key":"E00065","doi-asserted-by":"crossref","unstructured":"Salminen, E.K., Portin, R.I., Koskinen, A.I., Helenius, H.Y., & Nurmi, M.J. (2005). Estradiol and cognition during androgen deprivation in men with prostate carcinoma. <i>Cancer, 103<\/i>, 1381-1387.","DOI":"10.1002\/cncr.20962"},{"key":"E00066","doi-asserted-by":"crossref","unstructured":"Saykin, A.J., Ahles, T.A., & McDonald, B.C. (2003). Mechanisms of chemotherapy-induced cognitive disorders: Neuropsychological, patho-physiological, and neuroimaging perspectives. <i>Seminars in Clinical Neuropsychiatry, 8<\/i>, 201-216.","DOI":"10.1016\/S1084-3612(03)00055-8"},{"key":"E00067","doi-asserted-by":"crossref","unstructured":"Schagen, S.B., Hamburger, H.L., Muller, M.J., Boogerd, W., & van Dam, F.S. (2001). Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. <i>Journal of Neuro-Oncology, 51<\/i>, 159-165.","DOI":"10.1023\/A:1010635229762"},{"key":"E00068","doi-asserted-by":"crossref","unstructured":"Schagen, S.B., Muller, M.J., Boogerd, W., Mellenbergh, G.J., & van Dam, F.S. (2006). Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. <i>Journal of the National Cancer Institute, 98<\/i>, 1742-1745.","DOI":"10.1093\/jnci\/djj470"},{"key":"E00069","doi-asserted-by":"crossref","unstructured":"Schagen, S.B., Muller, M.J., Boogerd, W., Rosenbrand, R.M., van Rhijn, D., Rodenhuis, S., et al. (2002). Late effects of adjuvant chemotherapy on cognitive function: A follow-up study in breast cancer patients. <i>Annals of Oncology, 13<\/i>, 1387-1397.","DOI":"10.1093\/annonc\/mdf241"},{"key":"E00070","doi-asserted-by":"crossref","unstructured":"Schagen, S.B., van Dam, F.S., Muller, M.J., Boogerd, W., Lindeboom, J., & Bruning, P.F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. <i>Cancer, 85<\/i>, 640-650.","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G"},{"key":"E00071","doi-asserted-by":"crossref","unstructured":"Shilling, V., Jenkins, V., Fallowfield, L., & Howell, T. (2003). The effects of hormone therapy on cognition in breast cancer. <i>Journal of Steroid Biochemistry and Molecular Biology, 86<\/i>, 405-412.","DOI":"10.1016\/j.jsbmb.2003.07.001"},{"key":"E00072","doi-asserted-by":"crossref","unstructured":"Silberfarb, P.M. (1983). Chemotherapy and cognitive defects in cancer patients. <i>Annual Review of Medicine, 34<\/i>, 35-46.","DOI":"10.1146\/annurev.me.34.020183.000343"},{"key":"E00073","doi-asserted-by":"crossref","unstructured":"Silberfarb, P.M., Philibert, D., & Levine, P.M. (1980). Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients. <i>American Journal of Psychiatry, 137<\/i>, 597-601.","DOI":"10.1016\/0163-8343(80)90061-4"},{"key":"E00074","doi-asserted-by":"crossref","unstructured":"Sjogren, P., Olsen, A.K., Thomsen, A.B., & Dalberg, J. (2000). Neuropsychological performance in cancer patients: The role of oral opioids, pain and performance status. <i>Pain, 86<\/i>, 237-245.","DOI":"10.1016\/S0304-3959(00)00248-7"},{"key":"E00075","doi-asserted-by":"crossref","unstructured":"Smith, G.E., Petersen, R.C., Parisi, J.E., Ivnik, R.J., Kokmen, E., Tangalos, E.G., et al. (1996). Definition, course, and outcome of mild cognitive impairment. <i>Aging, Neuropsychology, and Cognition, 3<\/i>, 141-147.","DOI":"10.1080\/13825589608256619"},{"key":"E00076","doi-asserted-by":"crossref","unstructured":"Smith, M.Y., Redd, W.H., Peyser, C., & Vogl, D. (1999). Post-traumatic stress disorder in cancer: A review. <i>Psycho-Oncology, 8<\/i>, 521-537.","DOI":"10.1002\/(SICI)1099-1611(199911\/12)8:6<521::AID-PON423>3.0.CO;2-X"},{"key":"E00077","doi-asserted-by":"crossref","unstructured":"Staat, K., & Segatore, M. (2005). The phenomenon of chemo brain. <i>Clinical Journal of Oncology Nursing, 9<\/i>, 713-721.","DOI":"10.1188\/05.CJON.713-721"},{"key":"E00078","unstructured":"Sutton, J. (2004). Memory. In E.N. Zalta (Ed.), <i>Stanford encyclopedia of philosophy<\/i>. Retrieved February 1, 2007, from <a target=\"_blank\" href='http:\/\/plato.stanford.edu\/archives\/sum2004\/entries\/memory\/'>http:\/\/plato.stanford.edu\/archives\/sum2004\/entries\/memory\/<\/a>"},{"key":"E00079","doi-asserted-by":"crossref","unstructured":"Sweet, J.J., Doninger, N.A., Zee, P.C., & Wagner, L.I. (2004). Factors influencing cognitive function, sleep, and quality of life in individuals with systemic lupus erythematosus: A review of the literature. <i>Clinical Neuropsychology, 18<\/i>, 132-147.","DOI":"10.1080\/13854040490507244"},{"key":"E00080","doi-asserted-by":"crossref","unstructured":"Tannock, I.F., Ahles, T.A., Ganz, P.A., & van Dam, F.S. (2004). Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. <i>Journal of Clinical Oncology, 22<\/i>, 2233-2239.","DOI":"10.1200\/JCO.2004.08.094"},{"key":"E00081","doi-asserted-by":"crossref","unstructured":"Taylor, B.V., Buckner, J.C., Cascino, T.L., O'Fallon, J.R., Schaefer, P.L., Dinapoli, R.P., et al. (1998). Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma [see comment]. <i>Journal of Clinical Oncology, 16<\/i>, 2195-2201.","DOI":"10.1200\/JCO.1998.16.6.2195"},{"key":"E00082","doi-asserted-by":"crossref","unstructured":"Tchen, N., Juffs, H.G., Downie, F.P., Yi, Q.L., Hu, H., Chemerynsky, I., et al. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. <i>Journal of Clinical Oncology, 21<\/i>, 4175-4183.","DOI":"10.1200\/JCO.2003.01.119"},{"key":"E00083","unstructured":"U.S. Department of Health and Human Services. (2002). <i>121st National Cancer Advisory Board: Summary of meeting<\/i>. Bethesda: Department of Health and Human Services, National Institutes of Health, Retrieved January 31, 2007, from <a target=\"_blank\" href='http:\/\/deainfo.nci.nih.gov\/advisory\/ncab\/121_0202\/mins20feb02.pdf'>http:\/\/deainfo.nci.nih.gov\/advisory\/ncab\/121_0202\/mins20feb02.pdf<\/a>"},{"key":"E00084","unstructured":"van Dam, F.S., Schagen, S.B., Muller, M.J., Boogerd, W., vd Wall, E., Droogleever Fortuyn, M.E., et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. <i>Journal of the National Cancer Institute, 90<\/i>, 210-218."},{"key":"E00085","doi-asserted-by":"crossref","unstructured":"Vardy, J., Wong, K., Yi, Q.L., Park, A., Maruff, P., Wagner, L., et al. (2006). Assessing cognitive function in cancer patients. <i>Supportive Care in Cancer, 14<\/i>, 1111-1118.","DOI":"10.1007\/s00520-006-0037-6"},{"key":"E00086","unstructured":"Vas, C.J., Rajkumar, S., Tanyakitpisal, P., & Chandra, V. (2002). Alzheimer's disease: Of emerging importance. <i>Regional Health Forum, 6<\/i>(1), 39-48."},{"key":"E00087","doi-asserted-by":"crossref","unstructured":"Walker, L.G., Wesnes, K.P., Heys, S.D., Walker, M.B., Lolley, J., & Eremin, O. (1996). The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: A controlled clinical trial using computerised assessments. <i>European Journal of Cancer<\/i>, <b>32A<\/b>, 2275-2283.","DOI":"10.1016\/S0959-8049(96)00300-0"},{"key":"E00088","unstructured":"Walker, L.O., & Avant, K.C. (2005). <i>Strategies of theory construction in nursing<\/i>. Upper Saddle River, NJ: Pearson Education."},{"key":"E00089","doi-asserted-by":"crossref","unstructured":"Wallberg, B., Michelson, H., Nystedt, M., Bolund, C., Degner, L., & Wilking, N. (2003). The meaning of breast cancer. <i>Acta Oncologica, 42<\/i>, 30-35.","DOI":"10.1080\/0891060310002203"},{"key":"E00090","doi-asserted-by":"crossref","unstructured":"Wefel, J.S., Kayl, A.E., & Meyers, C.A. (2004). Neuropsychological dysfunction associated with cancer and cancer therapies: A conceptual review of an emerging target. <i>British Journal of Cancer, 90<\/i>, 1691-1696.","DOI":"10.1038\/sj.bjc.6601772"},{"key":"E00091","doi-asserted-by":"crossref","unstructured":"Wefel, J.S., Lenzi, R., Theriault, R., Buzdar, A.U., Cruickshank, S., & Meyers, C.A. (2004). \u2018Chemobrain\u2019 in breast carcinoma? A prologue. <i>Cancer, 101<\/i>, 466-475.","DOI":"10.1002\/cncr.20393"},{"key":"E00092","doi-asserted-by":"crossref","unstructured":"Wieneke, M.H., Dienst, E.R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. <i>Psycho-Oncology, 4<\/i>, 61-66.","DOI":"10.1002\/pon.2960040108"},{"key":"E00093","doi-asserted-by":"crossref","unstructured":"Wight, R.G., Aneshensel, C.S., & Seeman, T.E. (2002). Educational attainment, continued learning experience, and cognitive function among older men. <i>Journal of Aging and Health, 14<\/i>, 211-236.","DOI":"10.1177\/089826430201400203"},{"key":"E00094","unstructured":"Wikipedia. (2007a). Attention. Retrieved January 31, 2007, from <a target=\"_blank\" href='http:\/\/en.wikipedia.org\/wiki\/Attention'>http:\/\/en.wikipedia.org\/wiki\/Attention<\/a>"},{"key":"E00095","unstructured":"Wikipedia. (2007b). Executive functioning. Retrieved January 31, 2007, from <a target=\"_blank\" href='http:\/\/en.wikipedia.org\/wiki\/Executive_functioning'>http:\/\/en.wikipedia.org\/wiki\/Executive_functioning<\/a>"}],"container-title":["Oncology Nursing Forum"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/W5348N73K3603L2N.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:51:05Z","timestamp":1763754665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/onf\/34\/5\/chemotherapy-related-change-cognitive-function-conceptual-model"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9,1]]}},"alternative-id":["W5348N73K3603L2N"],"URL":"https:\/\/doi.org\/10.1188\/07.onf.981-994","relation":{},"ISSN":["0190-535X","1538-0688"],"issn-type":[{"value":"0190-535X","type":"print"},{"value":"1538-0688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}